- Home
- FLNG vs SYRE Comparison
FLNG vs SYRE Comparison
Compare FLNG & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNG
- SYRE
- Stock Information
- Founded
- FLNG 2006
- SYRE 2013
- Country
- FLNG Bermuda
- SYRE United States
- Employees
- FLNG N/A
- SYRE N/A
- Industry
- FLNG Marine Transportation
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- FLNG Consumer Discretionary
- SYRE Health Care
- Exchange
- FLNG Nasdaq
- SYRE Nasdaq
- Market Cap
- FLNG 1.3B
- SYRE 1.2B
- IPO Year
- FLNG N/A
- SYRE 2016
- Fundamental
- Price
- FLNG $21.97
- SYRE $18.03
- Analyst Decision
- FLNG Hold
- SYRE Strong Buy
- Analyst Count
- FLNG 1
- SYRE 8
- Target Price
- FLNG $23.00
- SYRE $51.50
- AVG Volume (30 Days)
- FLNG 667.7K
- SYRE 643.4K
- Earning Date
- FLNG 02-04-2025
- SYRE 05-08-2025
- Dividend Yield
- FLNG 13.63%
- SYRE N/A
- EPS Growth
- FLNG N/A
- SYRE N/A
- EPS
- FLNG 2.18
- SYRE N/A
- Revenue
- FLNG $356,349,000.00
- SYRE N/A
- Revenue This Year
- FLNG N/A
- SYRE N/A
- Revenue Next Year
- FLNG $3.58
- SYRE N/A
- P/E Ratio
- FLNG $9.97
- SYRE N/A
- Revenue Growth
- FLNG N/A
- SYRE N/A
- 52 Week Low
- FLNG $20.85
- SYRE $17.24
- 52 Week High
- FLNG $30.48
- SYRE $47.97
- Technical
- Relative Strength Index (RSI)
- FLNG 38.74
- SYRE 37.71
- Support Level
- FLNG $21.13
- SYRE $17.25
- Resistance Level
- FLNG $22.13
- SYRE $21.03
- Average True Range (ATR)
- FLNG 0.61
- SYRE 1.72
- MACD
- FLNG -0.00
- SYRE -0.08
- Stochastic Oscillator
- FLNG 37.33
- SYRE 16.86
About FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with state-of-the-art tonnage offering significant advantages in form of reduced fuel consumption and lowered boil-off rates.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.